Skip to main content
. Author manuscript; available in PMC: 2015 Nov 2.
Published in final edited form as: ACS Chem Biol. 2015 Jun 23;10(8):1831–1837. doi: 10.1021/acschembio.5b00442

Figure 5.

Figure 5

A) Comparison of HaloPROTAC3 (quintuplicate) to Hyt36 (triplicate) shows that HaloPROTAC3 is significantly more potent and efficacious. B) HaloPROTAC3 leads to 50% degradation of GFP-HaloTag7 within 4 to 8 hours. C) Significant recovery from 24 hour treatment with HaloPROTAC3 is observed after a 24 hour washout. All data was repeated in triplicate. Error bars depict the SEM.